Divi's Laboratories (DIVISLAB) — Board Meeting

Divi's Laboratories announced a special resolution to re-appoint Dr. Kiran S. Divi as Whole-time Director and CEO for five years starting April 1, 2025. The board meeting notice details e-voting via Kfin Technologies from February 5 to March 6, 2025, with results due March 8. Shareholders can vote remotely through NSDL, CDSL, or Kfintech platforms. The resolution includes remuneration terms, with annual salary of ₹9.24 crores and perquisites capped at 50% of salary. The re-appointment ensures leadership continuity, which may stabilize investor confidence. However, executive compensation at this level could pressure margins if performance targets are not met.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DIVISLAB ✨ Ask AI About This

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

📡 Get AI alerts when DIVISLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DIVISLAB — Free

💡 Ask AI about this filing

"How does this board meeting affect Divi's Laboratories Limited's outlook?" "What did Divi's Laboratories Limited announce on 4 February 2025?" "Is this positive or negative for DIVISLAB?"

Ask AI Free →

📊 More DIVISLAB filings

See all DIVISLAB filings →

🔥 Also filed on 4 February 2025

SBIN State Bank of India Financial Results SRF SRF Limited Financial Results TATAPOWER Tata Power Company Limited Financial Results TATAPOWER Tata Power Company Limited Financial Results TATAPOWER Tata Power Company Limited Financial Results RECLTD REC Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DIVISLAB files new disclosures

Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.